Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer development

The chronic Philadelphia-negative myeloproliferative neoplasms (MPNs) are acquired stem cell neoplasms which ultimately may transform to acute myelogenous leukemia. Most recently, chronic inflammation has been described as an important factor for the development and progression of MPNs in the biolog...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 12; no. 8; p. e0183620
Main Authors Andersen, Morten, Sajid, Zamra, Pedersen, Rasmus K, Gudmand-Hoeyer, Johanne, Ellervik, Christina, Skov, Vibe, Kjær, Lasse, Pallisgaard, Niels, Kruse, Torben A, Thomassen, Mads, Troelsen, Jesper, Hasselbalch, Hans Carl, Ottesen, Johnny T
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 31.08.2017
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The chronic Philadelphia-negative myeloproliferative neoplasms (MPNs) are acquired stem cell neoplasms which ultimately may transform to acute myelogenous leukemia. Most recently, chronic inflammation has been described as an important factor for the development and progression of MPNs in the biological continuum from early cancer stage to the advanced myelofibrosis stage, the MPNs being described as "A Human Inflammation Model for Cancer Development". This novel concept has been built upon clinical, experimental, genomic, immunological and not least epidemiological studies. Only a few studies have described the development of MPNs by mathematical models, and none have addressed the role of inflammation for clonal evolution and disease progression. Herein, we aim at using mathematical modelling to substantiate the concept of chronic inflammation as an important trigger and driver of MPNs.The basics of the model describe the proliferation from stem cells to mature cells including mutations of healthy stem cells to become malignant stem cells. We include a simple inflammatory coupling coping with cell death and affecting the basic model beneath. First, we describe the system without feedbacks or regulatory interactions. Next, we introduce inflammatory feedback into the system. Finally, we include other feedbacks and regulatory interactions forming the inflammatory-MPN model. Using mathematical modeling, we add further proof to the concept that chronic inflammation may be both a trigger of clonal evolution and an important driving force for MPN disease progression. Our findings support intervention at the earliest stage of cancer development to target the malignant clone and dampen concomitant inflammation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Competing Interests: C. Ellervik, V. Skov, L. Kjær, T.A. Kruse, M. Thomassen, M. Andersen, J.T. Ottesen, J. Troelsen, Z. Sajid, R.K. Pedersen and J. Gudmand-Hoeyer have no conflicts of interest to disclose. N. Pallisgaard has the following to disclose: consulting or advisory role for Qiagen and Novartis, participated in speakers bureau (Novartis and Roche), research funding (Incyte and Novartis), holds a patent (patent pending on contamination control of lymphocyte DNA when measuring cell free DNA in liquid biopsies), travel and accommodation (Novartis). H.C. Hasselbalch has the following to disclose: invited speaker and advisory role (Gilead), research funding (Novartis), travel and accommodation (Gilead, PharmaEssentia, Novartis). This does not alter our adherence to PLOS ONE policies on sharing data and materials.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0183620